View in EDS

Rarity & Risk of Secondary Hematologic Neoplasms after CAR T-cell Therapies.

Saved in:
Bibliographic Details
Title: Rarity & Risk of Secondary Hematologic Neoplasms after CAR T-cell Therapies.
Authors: Hamilton MP; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA., Alizadeh AA; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, 94305, USA.
Source: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Oct; Vol. 30 (10), pp. 936-938.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39326982
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Rarity & Risk of Secondary Hematologic Neoplasms after CAR T-cell Therapies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hamilton+MP%22">Hamilton MP</searchLink>; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Alizadeh+AA%22">Alizadeh AA</searchLink>; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, 94305, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101774629%22">Transplantation and cellular therapy</searchLink> [Transplant Cell Ther] 2024 Oct; Vol. 30 (10), pp. 936-938.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101774629 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-6367 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226666367%22">26666367 </searchLink><i>NLM ISO Abbreviation: </i>Transplant Cell Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39326982
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jtct.2024.09.002
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 936
    Titles:
      – TitleFull: Rarity & Risk of Secondary Hematologic Neoplasms after CAR T-cell Therapies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hamilton MP
      – PersonEntity:
          Name:
            NameFull: Alizadeh AA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2024 Oct
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2666-6367
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Transplantation and cellular therapy
              Type: main
ResultId 1